Biotechnological/Biological Products: About Its Stability Testing

  • Vivek P. Chavda B.K. Mody Government Pharmacy College
  • Dharmesh Shaliya Intas Pharmaceuticals Ltd
  • Bhargav Patel Zydus cadila pharmaceuticals Ltd
  • Ashish Gabani Intas Biopharmaceuticals Ltd
Keywords: Biologicals, Stability testing, rDNA technology

Abstract

The drug delivery systems have made some of the technological advances especially in the case of biopharmaceuticals. When one talks about biotechnological product stability of drug product becomes main culprit due to dynamic nature of drug molecule. This review is grafted using ICH and other regulatory guidelines to provide an overview to stability testing of such molecules.

Author Biographies

Vivek P. Chavda, B.K. Mody Government Pharmacy College

Department of Pharmaceutics,
B.K. Mody Government Pharmacy College,
Rajkot, Gujarat, India

Dharmesh Shaliya, Intas Pharmaceuticals Ltd

Quality Assurance, Intas Pharmaceuticals Ltd.,
Ahmedabad, Gujarat, India

Bhargav Patel, Zydus cadila pharmaceuticals Ltd

Quality Assurance, Zydus cadila pharmaceuticals Ltd.,
Ahmedabad, Gujarat, India

Ashish Gabani, Intas Biopharmaceuticals Ltd

Intas Biopharmaceuticals Ltd.,
Ahmedabad, Gujarat, India

References

1. Quality of biotechnological products: stability testing of biotechnological/biological products q5c. Ich harmonised tripartite guideline, 1995: p. 1-7.
2. Note for guidance on quality of biotechnological products: stability testing of biotechnological/biological products. European medical agency, 1996: p. 1-9.
Published
2016-05-01
How to Cite
[1]
Chavda, V., Shaliya, D., Patel, B. and Gabani, A. 2016. Biotechnological/Biological Products: About Its Stability Testing. PharmaTutor. 4, 5 (May 2016), 14-19.
Section
Articles